Pfizer (PFE) Q3 2023 Earnings Call Transcript : vimarsana.co

PFE earnings call for the period ending September 30, 2023.

Related Keywords

Japan , Terence Flynn Morgan Stanley , Robyn Karnauskas Truist , Akash Tewari , Geoff Meacham , Tim Anderson , Carter Gould Barclays , Andrew Baum Citi , Andrew Baum , Francesca Demartino , Robyn Karnauskas , David Risinger Leerink , Chris Shibutani Goldman Sachs , America Merrill Lynch , Albert Bourla , Mohit Bansal , Kerry Holford Berenberg , Aamir Malik , Angela Hwang , Dave Denton , David Risinger , Doug Lankler , Chris Boshoff , Kerry Holford , Chris Schott Jpmorgan , Chris Shibutani , Carter Gould , Chris Schott , Francesco Demartino , Evan Seigerman , Ivy Wang Jefferies , Mikael Dolsten , Steve Scala , Huynh Trung , Louise Chen , Terence Flynn , Louise Chen Cantor Fitzgerald , Wells Fargo , Company Analyst , Goldman Sachs , Tim Anderson Wolfe Research Analyst , Morgan Stanley , Barclays , Oncology Research , Pfizer , Worldwide Research , Geoff Meacham Bank , Wolfe Research , Vice President , Chief Investor Relations , Motley Fool Stock Advisor , Stock Advisor , Risk Factors , Forward Looking Information , Factors That May Affect Future , Chief Executive , North Star , Prevnar Pediatric , Geometric Mean Titer , Umer Raffat , Fargo Securities , Capital Markets , Although Seagen , Leerink Partners , Wells Fargo Securities , Chief Oncology Research , Berenberg Capital Markets ,